Digital transformation in diagnostics: What’s next?

Alex Clemente

Managing Director, Harvard Business Review Analytic Services

William Morice II, MD, PhD

Professor and Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President of Mayo Clinic Laboratories

Nick de Pennington

Digital Innovation & Population Health Lead, Oxford University Hospitals, National Health Service Foundation Trust, and CEO, Ufonia

Digital transformation in diagnostics: What’s next?

10 September 2020

Quick Takes

  • Data-driven diagnostics has the potential to improve patient outcomes and the cost-effectiveness of healthcare

  • Many healthcare organizations recognize the tremendous potential of data, yet struggle to unlock its full power

  • In a recently conducted global survey by Harvard Business Review Analytic Services, senior healthcare leaders share key insights and practices to facilitate successful digital transformation

Seizing the potential of data-driven diagnostics

Harvard Business Review Analytic Services (HBRAS) recently conducted a global survey of senior healthcare leaders sponsored by Roche. It found that leaders worldwide recognized the tremendous potential of the advanced use of data to improve health outcomes and improve the efficiency and cost-effectiveness of healthcare. 

However, many healthcare organizations are struggling to unlock the full power of data to drive decision making and improve performance. 

In this webinar, Alex Clemente summarizes the HBRAS survey findings about data-driven diagnostics in healthcare as he discusses: 

  • Key survey takeaways, including the behaviors and characteristics that differentiate leaders from laggards in digital transformation
  • Barriers to becoming more data driven 
  • Five practices that can facilitate transformation.

Following the presentation of the survey findings, Dr. William G. Morice of Mayo Clinic and Nick de Pennington of Oxford University Hospitals share their perspectives about digital transformation in healthcare, the challenges that must be overcome, and the impact of COVID-19.

MODERATOR:

Angelia Herrin, Editor, Special Projects and Research, Harvard Business Review Analytic Services

Alex Clemente Managing Director, Harvard Business Review Analytic Services

William Morice II, MD, PhD Professor and Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President of Mayo Clinic Laboratories

Nick de Pennington Digital Innovation & Population Health Lead, Oxford University Hospitals, National Health Service Foundation Trust, and CEO, Ufonia